The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice

Livia de Fraia Pinto, Cecília Melleti Compri, João Victor Fornari, Waldemar Bartchewsky, Dennys E. Cintra, Miriam Trevisan, Patrícia de Oliveira Carvalho, Marcelo Lima Ribeiro, Lı́cio A. Velloso, Mário J.A. Saad,

Liver International · 2010 · 45 citations · 24 references

Abstract

We suggest that immunosuppressant drugs that target TNF-alpha and that may also contribute to reductions in the inflammatory markers that are associated with obesity could be a therapeutic option in NAFLD and type 2 diabetes.

References

24